Whether it's the discovery of a novel target, the pursuit of a therapeutic biologic or small molecule, or the development of a novel vaccine, we have the right system for your budget, application, detection, and throughput needs. Together with our services, our high-performance bioanalytical systems will support the success of your drug discovery & development efforts, increasing productivity and cost effectiveness.
The power of the scientific knowledge discovered through the study of genomics and proteomics is driving an enormous wave of scientific investigation in the pursuit of new drug therapies to treat major diseases such as HIV/AIDS, cancer, diabetes, neurodegenerative diseases, and a wide range of inflammatory diseases. The search for these new therapies has now moved to the cellular level. The integration of genomics and proteomics together with the dynamic relationships between chemical and molecular events in living cells must be well understood to effectively pursue drug discovery.
Potential new therapies must be evaluated within the context of the living cell in order to measure biological behavior and function. Today's bottleneck in the race to new discoveries in life science research is cell-based analysis. Drug discovery research is hampered by the extended time and expense required to culture sufficient cells prior to analysis. There is a lack of ready access to cellular analysis systems, creating a delay in receiving reliable results and analyses from outsourced testing.
Molecular Devices provides a wide range of bioanalytical systems and detection methods that have direct relevance for drug discovery research. Whether it's the pursuit of a therapeutic biologic or small molecule, or of a novel diagnostic test or bioassay, we have the right system for your budget, application, detection, and throughput needs.
Together with our services, our high-performance bioanalytical systems can help you increase productivity and improve the cost-effectiveness of your drug discovery efforts. Please use the links below to learn more.
Drug discovery centers are working hard to maintain strong pipelines of novel therapeutic agents. To help, Molecular Devices has developed a wide range of bioanalytical systems and software to streamline workflows, improve productivity, and reduce costs.
To help reduce attrition rates and support drug development programs, Molecular Devices offers a range of bioassays as well as detection and analytical technologies to support bioprocessing, safety testing, and quality control.
Molecular Devices provides one of the broadest portfolios of bioanalytical systems and tools to investigate today's top priority target classes, including GPCRs, ion channels, kinases, and transporters.
With one of the deepest and broadest portfolios of bioanalytical products for drug discovery & development and a serious commitment to provide customers with expert application and technical support, Molecular Devices is well positioned to be your provider of choice.
Read What You Want When You Want with the new user-upgradeable SpectraMax Paradigm Multi-Mode Microplate Reader. Learn more.
Throughput: We have the right system for your lab--from single-readout instruments to automated, multi-detection systems.